Search

everythinglearnresearchcommunity

for

Search:↓

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

The 675-nm diode laser may safely help treat telogen effluvium.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

The document's conclusion cannot be determined without content.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Squaric acid dibutylester effectively treats alopecia areata.

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

A patient with complete hair loss regrew all her hair using tofacitinib.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Iron supplements combined with Quilib lotion effectively treat hair loss in people with iron deficiency anemia.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Scientists created tiny particles that release medicine on the skin and in hair, working better at certain pH levels and being safe for skin cells.

Tofacitinib taken by mouth helps treat hair loss in children.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.